BioSpace News Archive

Molecular Templates, Inc. announced that the 2020 Annual Meeting of Stockholders will be held virtually due to the public health impact of the novel coronavirus outbreak and to support the health and well-being of the Company’s management and stockholders.

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, announced its financial results for the first quarter ended March 31, 2020 and provided an update on recent corporate and clinical development highlights.

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2020, and provided an update on recent clinical achievements.

A world-renowned leader in infectious disease and transfusion medicine research, Vitalant Research Institute (VRI) is expanding plasma collections in San Francisco in the fight against COVID-19

Terri H. Finkel, M.D., Ph.D., a nationally known pediatric rheumatologist and immunologist, has joined Le Bonheur Children’s Hospital, the University of Tennessee Health Science Center and St. Jude Children’s Research Hospital in several leadership roles.

Junshi Biosciences (HKEX: 1877) a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, today announced that the China National Medical Products Administration (NMPA) has accepted a supplemental New Drug Application (sNDA) for toripalimab as a 2nd line treatment for patients with locally advanced or metastatic urothelial carcinoma who have received systemic therapy.

Merrimack Pharmaceuticals, Inc. announced its first quarter 2020 financial results for the period ended March 31, 2020.

Gladstone Institutes is launching two new biomedical research institutes to broaden its impact on unsolved diseases.

Achieves GAAP Profitability with $0.5 Million in Net Income in the First Quarter of 2020

ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, announced financial results for the quarter ended March 31, 2020.